117 related articles for article (PubMed ID: 3494482)
1. Measurement of radiation dose to the thyroid using positron emission tomography.
Ott RJ; Batty V; Webb BS; Flower MA; Leach MO; Clack R; Marsden PK; McCready VR; Bateman JE; Sharma H
Br J Radiol; 1987 Mar; 60(711):245-51. PubMed ID: 3494482
[TBL] [Abstract][Full Text] [Related]
2. Thyroid imaging using positron emission tomography--a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis.
Flower MA; Irvine AT; Ott RJ; Kabir F; McCready VR; Harmer CL; Sharma HL; Smith AG
Br J Radiol; 1990 May; 63(749):325-30. PubMed ID: 2198979
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
4. Tomographic imaging of the human thyroid using 124I.
Frey P; Townsend D; Flattet A; De Gautard R; Widgren S; Jeavons A; Christin A; Smith A; Long A; Donath A
J Clin Endocrinol Metab; 1986 Oct; 63(4):918-27. PubMed ID: 3488999
[TBL] [Abstract][Full Text] [Related]
5. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy.
Flower MA; al-Saadi A; Harmer CL; McCready VR; Ott RJ
Eur J Nucl Med; 1994 Jun; 21(6):531-6. PubMed ID: 8082669
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of the human thyroid with a positron camera using 124I.
Frey P; Townsend D; Jeavons A; Donath A
Eur J Nucl Med; 1985; 10(9-10):472-6. PubMed ID: 3874064
[TBL] [Abstract][Full Text] [Related]
7. Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography.
Crawford DC; Flower MA; Pratt BE; Hill C; Zweit J; McCready VR; Harmer CL
Eur J Nucl Med; 1997 Dec; 24(12):1470-8. PubMed ID: 9391181
[TBL] [Abstract][Full Text] [Related]
8. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
[TBL] [Abstract][Full Text] [Related]
9. Low-activity (124)I-PET/low-dose CT versus (131)I probe measurements in pretherapy assessment of radioiodine uptake in benign thyroid diseases.
Westphal JG; Winkens T; Kühnel C; Freesmeyer M
J Clin Endocrinol Metab; 2014 Jun; 99(6):2138-45. PubMed ID: 24606104
[TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
Boerner AR; Voth E; Theissen P; Wienhard K; Wagner R; Schicha H
Thyroid; 1998 Sep; 8(9):765-72. PubMed ID: 9777746
[TBL] [Abstract][Full Text] [Related]
11. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
[TBL] [Abstract][Full Text] [Related]
12. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
Giovanella L; Avram AM; Iakovou I; Kwak J; Lawson SA; Lulaj E; Luster M; Piccardo A; Schmidt M; Tulchinsky M; Verburg FA; Wolin E
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2514-2525. PubMed ID: 31392371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
[TBL] [Abstract][Full Text] [Related]
14. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
Eschner W; Kobe C; Schicha H
Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
[TBL] [Abstract][Full Text] [Related]
16. 131I dose to the human fetal thyroid in the Zagreb district, Yugoslavia, from the Chernobyl accident.
Basić M; Kasal B; Simonović I; Jukić S
Int J Radiat Biol; 1988 Aug; 54(2):167-77. PubMed ID: 2900274
[TBL] [Abstract][Full Text] [Related]
17. The effect of gadolinium contrast media on radioiodine uptake by the thyroid gland.
Christensen CR; Glowniak JV; Brown PH; Morton KA
J Nucl Med Technol; 2000 Mar; 28(1):41-4. PubMed ID: 10763780
[TBL] [Abstract][Full Text] [Related]
18. A clinical evaluation of a prototype positron camera for longitudinal emission tomography.
Flower MA; Ott RJ; Webb S; Leach MO; Marsden P; Khan O; McCready VR; Bateman JE; Flesher AC; Sharma HL
Br J Radiol; 1984 Dec; 57(684):1103-17. PubMed ID: 6334540
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of 24-hour thyroid 131I uptake between γ camera-based method using medium-energy collimator and standard uptake probe-based method.
Menon BK; Rao RD; Abhyankar A; Rajan MG; Basu S
J Nucl Med Technol; 2014 Sep; 42(3):194-7. PubMed ID: 24970896
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose to patients and relatives incident to 131I therapy.
Zanzonico PB
Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
